logo

For the Inventor, By the Inventor

Vizcaya, Spain

Simon Santa Cruz

This inventor holds 1 USPTO granted patent. Top assignee: Progenika Biopharma S.a.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Santa Cruz. Retrieved from https://idiyas.com/inventor/simon-santa-cruz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 16 
 
Progenika Biopharma S.a.
 patents

Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents
1. 8124331 - In vitro method to detect bladder transitional cell carcinoma (2012-02-28),

Title: Simon Santa Cruz: Innovator in Cancer Detection

Introduction

Simon Santa Cruz is a notable inventor based in Vizcaya, Spain. He has made significant contributions to the field of medical diagnostics, particularly in cancer detection. His innovative work focuses on developing methods that can improve the diagnosis and treatment of bladder cancer.

Latest Patents

Simon Santa Cruz holds a patent for an "In vitro method to detect bladder transitional cell carcinoma." This invention refers to a method that allows for the detection of bladder transitional cell carcinoma in individuals. It aims to determine the stage or severity of the cancer and monitor the effects of therapy administered to patients. Additionally, the method is designed to screen for, identify, develop, and evaluate the efficacy of therapeutic compounds against this cancer. It also focuses on developing new medicinal products and agents that inhibit the expression and/or activity of the FGFR3 protein.

Career Highlights

Simon Santa Cruz is associated with Progenika Biopharma S.A., a company dedicated to advancing biopharmaceutical innovations. His work at Progenika Biopharma has allowed him to collaborate with other experts in the field, enhancing the impact of his research.

Collaborations

Some of his notable coworkers include Antonio Martínez Martínez and María Pilar Sáenz Jiménez. Their collaboration has contributed to the advancement of research and development in cancer diagnostics.

Conclusion

Simon Santa Cruz's contributions to cancer detection through his innovative patent demonstrate his commitment to improving medical diagnostics. His work has the potential to significantly impact the treatment and management of bladder cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…